MARTA
ALONSO PEÑA
Investigadora en el periodo 2015-2019
Hospital Universitario Marqués de Valdecilla
Santander, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Marqués de Valdecilla (10)
2024
-
Clinical and genetic factors involved in Porto-sinusoidal vascular disorder after oxaliplatin exposure
Digestive and Liver Disease
2023
-
Innovative Therapeutic Approaches in Non-Alcoholic Fatty Liver Disease: When Knowing Your Patient Is Key
International Journal of Molecular Sciences, Vol. 24, Núm. 13
-
The Cantabria Cohort, a protocol for a population-based cohort in northern Spain
BMC Public Health, Vol. 23, Núm. 1
2022
-
Beneficial effect of ursodeoxycholic acid in patients with acyl-CoA oxidase 2 (ACOX2) deficiency–associated hypertransaminasemia
Hepatology, Vol. 76, Núm. 5, pp. 1259-1274
-
Impact of Liver Inflammation on Bile Acid Side Chain Shortening and Amidation
Cells, Vol. 11, Núm. 24
-
Pathophysiological mechanisms in non-alcoholic fatty liver disease: From drivers to targets
Biomedicines, Vol. 10, Núm. 1
2021
-
Immune assessment of BNT162b2 m-RNA-spike based vaccine response in adults
Biomedicines, Vol. 9, Núm. 8
-
Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity
Frontiers in Immunology, Vol. 12
-
Innate and adaptive immune assessment at admission to predict clinical outcome in covid-19 patients
Biomedicines, Vol. 9, Núm. 8
-
Myeloid-Derived Suppressor Cells Are Increased in Lung Transplant Recipients and Regulated by Immunosuppressive Therapy
Frontiers in Immunology, Vol. 12